Insider buying last 90 days
No open-market insider purchases were filed for BAX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every BAX insider filing, plotted on the chart in Gekko.Open BAX in Gekko
NYSE: BAX
Baxter International (BAX) Stock Analysis & Forecast
Sep 28 close
$23.49+0.12 (+0.5%)
Gekko Brief
Baxter International closed at $23.49 on 28 September 2026, +0.5% on the day. The price sits between the 50-day ($25.11) and 200-day ($20.74) moving averages, inside a 52-week range of $15.73 to $30.00. The GekkoIndex reads 65.4, in the Accumulation zone, down 9.9 points over five sessions. Gekko Fair Value is $26.56, so the price is 11.6% below it.
The next earnings report is due on 29 October 2026, 30 days away (before open). Over the last 8 reports the company beat the earnings estimate 5 times, with an average move of 9.3% across the report. Seasonally, the next 20 trading days from this point averaged -1.8% over the last 5 years, rising in 3 of them.
10 firms rate the stock: 1 buy, 9 hold and 0 sell, with a consensus target of $28.73. A typical daily move is about 3%, and a typical 20-day move about 6.6%. On the swing-trade checklist, 3 items read supportive and 0 read as a headwind.
Generated Sep 29, 2026 from the data above.
Baxter International price vs fair value
Close $23.49200-day averageGekko Fair Value $26.56
Baxter International quick facts
- Market cap
- $12.14B
- P/E ratio
- —
- Forward P/E
- 11.6
- EPS, TTM
- −$1.88
- Revenue, TTM
- $11.47B
- Profit margin
- -9.3%
- Dividend yield
- 0.85%
- Beta
- 0.60
- Volume
- 6.17M avg 6.51M
- 1-year return
- +8.2%
- Typical daily move
- ±3%
- Typical 20-day move
- ±6.6%
- 50-day average
- $25.11
- 200-day average
- $20.74
- Next earnings
- Oct 29 before open
- Shares outstanding
- 517.0M
Baxter International swing-trade checklist
Baxter International scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
- Trendmixed
Averages disagree
Close $23.49 sits between the 50-day ($25.11) and 200-day ($20.74) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
65.4, Accumulation
Reading 65.4 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
11.6% below
Price is 11.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 30 days
Next report Oct 29, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
−1.8% on average
From this point in the calendar, the next 20 trading days averaged −1.8% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Baxter International stock chart and price history
Baxter International closed at $23.49 on Sep 28, 2026, +8.2% over the past year, inside a 52-week range of $15.73 to $30.00.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −9.4%
- 3 months
- +6.7%
- 6 months
- +47.1%
- 1 year
- +8.2%
The full BAX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open BAX in Gekko
Follow Baxter International through every session
Put BAX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track BAX in GekkoFree for 7 days. No credit card required.
About Baxter International
Baxter International makes a broad range of healthcare products used in treating serious and chronic conditions. Its offerings span dialysis care for kidney patients, intravenous fluids and infusion equipment, drug compounding and pharmacy services, nutrition therapies given outside normal eating, and surgical products used to control bleeding, seal tissue and limit adhesions during operations. It is also recognized for connected care systems that combine monitoring devices, software and communication tools used across hospitals and clinics.
The company reaches patients through hospitals, dialysis centers, nursing and rehabilitation facilities, doctors' offices, and home care settings. It sells through a mix of its own sales staff, independent distributors, drug wholesalers and specialty pharmacies, and it works with roughly 100 countries worldwide. Baxter also performs contract work for other pharmaceutical and biopharmaceutical firms, and has a partnership with Celerity Pharmaceutical focused on generic injectable and oncolytic drug development.
Baxter International was founded in 1931 and is headquartered in Deerfield, Illinois. Its shares are listed on the NYSE under the ticker BAX.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- baxter.com
Baxter International GekkoIndex: the smart money zone
Baxter International’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.4, in the Accumulation zone, down 9.9 points over five sessions.
65.4Accumulation
Down 9.9 points over five sessions, from the Buying zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 83 | +0.1% | 0.0% | ||
| Accumulation (current zone) | 227 | −0.6% | −1.7% | ||
| Neutral | 335 | 0.0% | −0.5% | ||
| Distribution | 26 | −1.3% | −1.9% | ||
| Selling | 1 | Too few readings yet | |||
Average BAX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the BAX price, zone by zone.Track BAX in Gekko
Is Baxter International stock overvalued? Gekko Fair Value
Baxter International trades 11.6% below Gekko Fair Value of $26.56, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Baxter International shares are worth, recalculated every trading day.
$26.56
Gekko Fair Value, Sep 29, 2026
11.6% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open BAX in Gekko
Baxter International insider and Congress trading
No open-market insider purchases were filed for Baxter International, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in BAX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for BAX, plotted on the chart in Gekko.Open BAX in Gekko
Buybacks
Baxter International has been buying back its own shares.
- Bought back, quarter ended Sep 30, 2022
- $32.00M
- As a share of market cap
- 0.26%
From company filings.
Hedge funds and billionaires quarter ended Dec 31
0of the funds Gekko tracks hold BAX.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
Baxter International earnings: next date and track record
Baxter International reports on Oct 29, 2026, before the open (30 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected before the open, 30 days away
- EPS estimate
- $0.52
- Revenue estimate
- $2.91B
5 of 8reports beat the EPS estimate
±9.3%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Baxter reported Q2 2026 sales of ~$3 billion, up 5% organically, with growth across all segments led by Advanced Surgery and Drug Compounding. Adjusted EPS was $0.56 vs $0.59 prior year, including an unexpected $0.11 benefit from a $75M tariff refund. Excluding the tariff benefit, margins still exceeded expectations. Novum IQ LVP pump remains under regulatory review with corrections in early verification testing.
- Guidance
- Baxter raised full-year organic sales growth outlook based on strong Q2 and back-half confidence. Adjusted EPS outlook increased to reflect the tariff refund. Management expects H2 margin expansion driven by higher volumes, cost structure actions, and inventory normalization.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.56 est $0.36 | $2.96B est $2.80B | +5.6% |
| Apr 30, 2026 | $0.36 est $0.31 | $2.70B est $2.62B | +1.8% |
| Feb 12, 2026 | $0.44 est $0.55 | $2.97B est $2.82B | −11.2% |
| Oct 30, 2025 | $0.69 est $0.60 | $2.84B est $2.82B | −17.6% |
| Jul 31, 2025 | $0.59 est $0.61 | $2.81B est $2.88B | −21.7% |
| May 1, 2025 | $0.55 est $0.48 | $2.63B est $2.59B | −1.5% |
| Feb 20, 2025 | $0.58 est $0.52 | $2.75B est $2.67B | +9.7% |
| Nov 8, 2024 | $0.49 est $0.78 | $2.70B est $3.85B | −5.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Baxter International stock forecast and analyst price targets
Analysts’ average 12-month price target for Baxter International is $28.73, +22.3% from the last close, from 10 firms rating the stock in the last 90 days.
$28.73consensus 12-month target, +22.3% from the last close
Now $23.49Avg $28.73
Low $21High $29
Each firm’s latest rating in the last 90 days: 10 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 13 | Citi | $28 | +19.2% |
| Aug 11 | Bank of America Securities | $28 | +19.2% |
| Aug 6 | J.P. Morgan | $26 | +10.7% |
| Jul 31 | Deutsche Bank | $27 | +14.9% |
| Jul 31 | TD Cowen | $29 | +23.5% |
−1.7%average 20-day move after past Accumulation readings
−1.8%average move over the next 20 trading days in the last 5 years
±3%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Baxter International seasonality: the next 20 trading days
Over the next 20 trading days from Sep 26, Baxter International averaged −1.8% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.4% | 2 of 5 |
| Next 10 trading days | −0.7% | 1 of 5 |
| Next 15 trading days | −3.2% | 2 of 5 |
| Next 20 trading days | −1.8% | 3 of 5 |
| Next 30 trading days | −7.8% | 0 of 5 |
For scale, BAX’s typical 20-trading-day move in either direction is about 6.6%.
Baxter International market cap and key statistics
Baxter International’s market cap is $12.14B and revenue of $11.47B over the last twelve months.
Valuation
- Market cap
- $12.14B
- Forward P/E
- 11.6
- EPS, TTM
- −$1.88
- Gekko Fair Value
- $26.56
Trading
- Volume
- 6.17M
- Avg volume, 20 days
- 6.51M
- 52-week high
- $30.00
- 52-week low
- $15.73
- Shares outstanding
- 517.0M
Financials
- Revenue, TTM
- $11.47B
- Profit margin
- -9.3%
- Return on equity
- -14.4%
- Quarterly earnings growth, YoY
- +36.8%
Risk and income
- Beta
- 0.60
- Typical daily move
- ±3%
- Typical 20-day move
- ±6.6%
- Dividend yield
- 0.85%
Baxter International stock news this week
Coverage of Baxter International this week reads negative: 1 positive, 2 neutral and 3 negative headlines.
- Baxter International stock heads into the open after a 1.9 percent S&P 500 dropAD HOC NEWS, Sep 25
- Here's Why You Should Retain Baxter Stock in Your Portfolio for NowTradingView, Sep 24
- Baxter International stock heads into the open after a 1.2 percent dropAD HOC NEWS, Sep 24
- Baxter International stock holds at USD 22.93 as storm damage weighsAD HOC NEWS, Sep 23
- Baxter International stock holds near its yearly highAD HOC NEWS, Sep 22
- Baxter International, McDowell CountyYahoo, Sep 22
Baxter International peers
Baxter International’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
Baxter International stock FAQ
What is Baxter International’s market cap?
Baxter International’s market cap is $12.14B at the Sep 28, 2026 close of $23.49, with 517.0M shares outstanding.
What is the Baxter International stock forecast?
The consensus analyst 12-month price target for Baxter International is $28.73, +22.3% from the last close. Of the 10 firms that rated the stock in the last 90 days, 1 rate it a buy, 9 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Baxter International stock overvalued or undervalued?
On Gekko’s estimate Baxter International is undervalued: the Sep 28, 2026 close of $23.49 is 11.6% below Gekko Fair Value of $26.56. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Baxter International report earnings next?
Baxter International is expected to report on Oct 29, 2026, before the market opens (30 days away). Analysts expect earnings of $0.52 per share on revenue of $2.91B. Baxter International beat the earnings estimate in 5 of its last 8 reports, moving 9.3% on average across the report.
What is Baxter International’s 52-week high and low?
Baxter International’s 52-week high is $30.00 and its 52-week low is $15.73; it closed at $23.49 on Sep 28, 2026, +8.2% over the past year. Over the last five years the shares peaked at $89.70 on Feb 9, 2022.
Is Baxter International stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 2 as mixed (trend and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Baxter International the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.